Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Transmissible gastroenteritis coronavirus RNA-dependent RNA polymerase and nonstructural proteins 2, 3, and 8 are incorporated into viral particles

  • Nogales, Aitor
  • Márquez-Jurado, Silvia
  • Galán, Carmen
  • Enjuanes Sánchez, Luis
  • Almazán, Fernando
Coronavirus replication and transcription are processes mediated by a protein complex, with the RNA-dependent RNA polymerase (RdRp) as a main component. Proteomic analysis of highly purified transmissible gastroenteritis virus showed the RdRp to be a component of the viral particles. This finding was confirmed by Western blotting, immunofluorescence, and immunoelectron microscopy analyses. Interestingly, the replicase nonstructural proteins 2, 3, and 8 colocalized with the RdRp in the viral factories and were also incorporated into the virions. © 2012, American Society for Microbiology., This work was supported by grants from the Ministry of Science and Innovation of Spain (MCINN) (BIO2010-16705), the Spanish National Research Council (CSIC) (project 200920I024), the Community of Madrid (S-SAL-0185-2006), the European Community’s Seventh Framework Programme (FP7/2007-2013) under the projects “PLAPROVA” (KBBE-227056) and “PoRRSCon” (EC grant agreement number 245141), and Pfizer Animal Health. S.M.-J. received a predoctoral fellowship from National Institute of Health (ISCIII) of Spain. A.N. and C.G. received a contract from the Spanish National Research Council (CSIC).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Immunogenic characterization and epitope mapping of transmissible gastroenteritis virus RNA dependent RNA polymerase

  • Nogales, Aitor
  • Galán, Carmen
  • Márquez-Jurado, Silvia
  • García-Gallo, Mónica
  • Kremer, Leonor
  • Enjuanes Sánchez, Luis
  • Almazán, Fernando
Coronavirus RNA synthesis is a sophisticated process performed by a viral multienzymatic replicase complex, together with cellular factors. A key enzyme of this replication complex is the RNA dependent RNA polymerase (RdRp). To study the replication of coronavirus genome, six monoclonal antibodies (mAbs) specific for transmissible gastroenteritis virus (TGEV) RdRp were generated and characterized. His-tagged RdRp was expressed in baculovirus, purified and used as immunogen to produce mAbs. The TGEV RdRp was recognized by these mAbs in the context of virus infection by immunofluorescence analysis and Western blot. Epitope mapping by Pepscan indicated that RdRp mAbs recognized four non-overlapping linear epitopes located in a 62-amino acid region of the N-terminal domain, suggesting that this region may constitute an immunodominant domain. The availability of TGEV RdRp mAbs will be instrumental to study coronavirus replication and to analyze the function of RdRp in pathogenesis., This work was supported by grants from the Ministry of Science and Innovation of Spain (MCINN) (BIO2010-16705), the Spanish National Research Council (CSIC) (projects 200920I024, 200920I016 and 201120E007), the Community of Madrid (S-SAL-0185-2006), the European Community's Seventh Framework Programme (FP7/2007-2013) under the projects “PLAPROVA” (KBBE-227056) and “EMPERIE” (223498), and Pfizer Animal Health. AN and SM received a predoctoral fellowship from MCINN and from National Institute of Health (ISCIII) of Spain, respectively. CG and MG received a contract from the Spanish National Research Council (CSIC).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Recombinant live vaccines to protect against the severe acute respiratory syndrome coronavirus

  • Enjuanes Sánchez, Luis
  • Nieto-Torres, José L.
  • Jiménez-Guardeño, José Manuel
  • DeDiego, Marta L.
The severe acute respiratory syndrome (SARS) coronavirus (CoV) was identified as the etiological agent of an acute respiratory disease causing atypical pneumonia and diarrhea with high mortality. Different types of SARS-CoV vaccines, including nonreplicative and vectored vaccines, have been developed. Administration of these vaccines to animal model systems has shown promise for the generation of efficacious and safe vaccines. Nevertheless, the identification of side effects, preferentially in the elderly animal models, indicates the need to develop novel vaccines that should be tested in improved animal model systems. Live attenuated viruses have generally proven to be the most effective vaccines against viral infections. A limited number of SARS-CoV attenuating modifications have been described, including mutations, and partial or complete gene deletions affecting the replicase, like the nonstructural proteins (nsp1 or nsp2), or the structural genes, and drastic changes in the sequences that regulate the expression of viral subgenomic mRNAs. A promising vaccine candidate developed in our laboratory was based on deletion of the envelope E gene alone, or in combination with the removal of six additional genes nonessential for virus replication. Viruses lacking E protein were attenuated, grew in the lung, and provided homologous and heterologous protection. Improvements of this vaccine candidate have been directed toward increasing virus titers using the power of viruses with mutator phenotypes, while maintaining the attenuated phenotype. The safety of the live SARS-CoV vaccines is being increased by the insertion of complementary modifications in genes nsp1, nsp2, and 3a, by gene scrambling to prevent the rescue of a virulent phenotype by recombination or remodeling of vaccine genomes based on codon deoptimization using synthetic biology. The newly generated vaccinecandidates are very promising, but need to be evaluated in animal model systems that include young and aged animals., This work was supported by grants from the Comisión Interministerial de Ciencia y Tecnología (CICYT) Bio2007 – 60978, the Consejería de Educación y Cultura de la Comunidad de Madrid S-SAL-0185/06, Ministerio de Ciencia e Innovación (MICINN) Project PROFIT, CIT-010000-2007-8, Fort Dodge Veterinaria, and the European Communities (Frame VII, EMPERIE project HEALTH-F3-2009-223498, and PLAPROVA project KBBE-2008-227056). MLD, JLN, and JMJ received fellowships from the Department of Education and Science of Spain. The work is also supported by a grant from the National Institutes of Health (US) RO1 AI079424-01A1, W000151845 (LE).